p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels

Journal of Cell Science

Volumn 124, Issue 10, 2011, Pages 1635-1643

  McDade, Simon S ^a   Patel, Daksha ^a   McCance, Dennis J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Keratinocyte; p63; Proliferation

Indexed keywords

ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; ISOPROTEIN; MESSENGER RNA; PROTEIN P107; PROTEIN P130; PROTEIN P21; PROTEIN P53; PROTEIN P63; PROTEIN P63 ALPHA; PROTEIN P63 BETA; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BIOACCUMULATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; HUMAN; HUMAN CELL; INTRON; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN RNA BINDING; REGULATORY MECHANISM;

CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; PROTEIN ISOFORMS; RETINOBLASTOMA-LIKE PROTEIN P130; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 79956088481     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.084723     Document Type: Article

References (53)

1. Barre, B. and Perkins, N. D. (2010). The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol. Cell 38, 524-538.
2. Bauzon, F. and Zhu, L. (2010). Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality. Cell Cycle 9, 2118-2123.
3. Beretta, C., Chiarelli, A., Testoni, B., Mantovani, R. and Guerrini, L. (2005). Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63. Cell Cycle 4, 1625-1631.
4. Bhattacharya, S., Garriga, J., Calbo, J., Yong, T., Haines, D. S. and Grana, X. (2003). SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 22, 2443-2451.
5. Candi, E., Terrinoni, A., Rufini, A., Chikh, A., Lena, A. M., Suzuki, Y., Sayan, B. S., Knight, R. A. and Melino, G. (2006). p63 is upstream of IKK alpha in epidermal development. J. Cell Sci. 119, 4617-4622.
6. Candi, E., Rufini, A., Terrinoni, A., Giamboi-Miraglia, A., Lena, A. M., Mantovani, R., Knight, R. and Melino, G. (2007). DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc. Natl. Acad. Sci. USA 104, 11999-12004.
7. Choi, H. H., Jong, H. S., Hyun Song, S., You Kim, T., Kyeong Kim, N. and Bang, Y. J. (2002). p130 mediates TGF-beta-induced cell-cycle arrest in Rb mutant HT-3 cells. Gynecol. Oncol. 86, 184-189.
8. DeGregori, J. (2004). The Rb network. J. Cell Sci. 117, 3411-3413.
9. Deyoung, M. P. and Ellisen, L. W. (2007). p63 and p73 in human cancer: defining the network. Oncogene 26, 5169-5183.
10. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr, Butel, J. S. and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.
11. Frescas, D. and Pagano, M. (2008). Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438-449.
12. Galli, F., Rossi, M., D'Alessandra, Y., De Simone, M., Lopardo, T., Haupt, Y., Alsheich-Bartok, O., Anzi, S., Shaulian, E., Calabro, V. et al. (2010). MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J. Cell Sci. 123, 2423-2433.
13. Gatza, C., Moore, L., Dumble, M. and Donehower, L. A. (2007). Tumor suppressor dosage regulates stem cell dynamics during aging. Cell Cycle 6, 52-55.
14. Gstaiger, M., Jordan, R., Lim, M., Catzavelos, C., Mestan, J., Slingerland, J. and Krek, W. (2001). Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. USA 98, 5043-5048.
15. Guo, X., Keyes, W. M., Papazoglu, C., Zuber, J., Li, W., Lowe, S. W., Vogel, H. and Mills, A. A. (2009). TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat. Cell Biol. 11, 1451-1457.
16. Helmbold, H., Komm, N., Deppert, W. and Bohn, W. (2009). Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence. Oncogene 28, 3456-3467.
17. Herzinger, T., Wolf, D. A., Eick, D. and Kind, P. (1995). The pRb-related protein p130 is a possible effector of transforming growth factor beta 1 induced cell cycle arrest in keratinocytes. Oncogene 10, 2079-2084.
18. Ihrie, R. A., Marques, M. R., Nguyen, B. T., Horner, J. S., Papazoglu, C., Bronson, R. T., Mills, A. A. and Attardi, L. D. (2005). Perp is a p63-regulated gene essential for epithelial integrity. Cell 120, 843-856.
19. Incassati, A., Patel, D. and McCance, D. J. (2006). Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Oncogene 25, 2444-2451.
20. Irwin, M. S. and Kaelin, W. G., Jr (2001). Role of the newer p53 family proteins in malignancy. Apoptosis 6, 17-29.
21. Keyes, W. M., Vogel, H., Koster, M. I., Guo, X., Qi, Y., Petherbridge, K. M., Roop, D. R., Bradley, A. and Mills, A. A. (2006). p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. Proc. Natl. Acad. Sci. USA 103, 8435-8440.
22. Kouwenhoven, E. N., van Heeringen, S. J., Tena, J. J., Oti, M., Dutilh, B. E., Alonso, M. E., de la Calle-Mustienes, E., Smeenk, L., Rinne, T., Parsaulian, L. et al. (2010). Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet. 6, e1001065.
23. Lee, H. and Kimelman, D. (2002). A dominant-negative form of p63 is required for epidermal proliferation in zebrafish. Dev. Cell 2, 607-616.
24. Lefkimmiatis, K., Caratozzolo, M. F., Merlo, P., D'Erchia, A. M., Navarro, B., Levrero, M., Sbisa, E. and Tullo, A. (2009). p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes. Cancer Res. 69, 8563-8571.
25. Lin, H. K., Chen, Z., Wang, G., Nardella, C., Lee, S. W., Chan, C. H., Yang, W. L., Wang, J., Egia, A., Nakayama, K. I. et al. (2010). Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 464, 374-379.
26. McCance, D. J., Kopan, R., Fuchs, E. and Laimins, L. A. (1988). Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 85, 7169-7173.
27. McDade, S. S. and McCance, D. J. (2010). The role of p63 in epidermal morphogenesis and neoplasia. Biochem. Soc. Trans. 38, 223-228.
28. McKenna, D. J., McDade, S. S., Patel, D. and McCance, D. J. (2010). MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J. Virol. 84, 10644-10652.
29. Mills, A. A., Zheng, B., Wang, X. J., Vogel, H., Roop, D. R. and Bradley, A. (1999). p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398, 708-713.
30. Minner, F. and Poumay, Y. (2009). Candidate housekeeping genes require evaluation before their selection for studies of human epidermal keratinocytes. J. Invest. Dermatol. 129, 770-773.
31. Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L. H., Livingston, D. M. and Dotto, G. P. (1995). Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1Aassociated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92, 5451-5455.
32. Nguyen, B. C., Lefort, K., Mandinova, A., Antonini, D., Devgan, V., Della Gatta, G., Koster, M. I., Zhang, Z., Wang, J., Tommasi di Vignano, A. et al. (2006). Crossregulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 20, 1028-1042.
33. Park, B. J., Lee, S. J., Kim, J. I., Lee, C. H., Chang, S. G., Park, J. H. and Chi, S. G. (2000). Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res. 60, 3370-3374.
34. Rinne, T., Brunner, H. G. and van Bokhoven, H. (2007). p63-associated disorders. Cell Cycle 6, 262-268.
35. Rossi, M., De Simone, M., Pollice, A., Santoro, R., La Mantia, G., Guerrini, L. and Calabro, V. (2006). Itch/AIP4 associates with and promotes p63 protein degradation. Cell Cycle 5, 1816-1822.
36. Schavolt, K. L. and Pietenpol, J. A. (2007). p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Oncogene 26, 6125-6132.
37. Sniezek, J. C., Matheny, K. E., Westfall, M. D. and Pietenpol, J. A. (2004). Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope 114, 2063-2072.
38. Su, X., Chakravarti, D., Cho, M. S., Liu, L., Gi, Y. J., Lin, Y. L., Leung, M. L., El-Naggar, A., Creighton, C. J., Suraokar, M. B. et al. (2010). TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467, 986-990.
39. Topley, G. I., Okuyama, R., Gonzales, J. G., Conti, C. and Dotto, G. P. (1999). p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc. Natl. Acad. Sci. USA 96, 9089-9094.
40. Tron, V. A., Trotter, M. J., Tang, L., Krajewska, M., Reed, J. C., Ho, V. C. and Li, G. (1998). p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes. Am. J. Pathol. 153, 579-585.
41. Truong, A. B., Kretz, M., Ridky, T. W., Kimmel, R. and Khavari, P. A. (2006). p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 20, 3185-3197.
42. Ueno, T., Sasaki, K., Yoshida, S., Kajitani, N., Satsuka, A., Nakamura, H. and Sakai, H. (2006). Molecular mechanisms of hyperplasia induction by human papillomavirus E7. Oncogene 25, 4155-4164.
43. Wang, H., Bauzon, F., Ji, P., Xu, X., Sun, D., Locker, J., Sellers, R. S., Nakayama, K., Nakayama, K. I., Cobrinik, D. et al. (2010). Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice. Nat. Genet. 42, 83-88.
44. Wang, X. and Seed, B. (2003). A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 31, e154.
45. Westbrook, T. F., Nguyen, D. X., Thrash, B. R. and McCance, D. J. (2002). E7 abolishes raf-induced arrest via mislocalization of p21(Cip1). Mol. Cell. Biol. 22, 7041-7052.
46. Westfall, M. D., Mays, D. J., Sniezek, J. C. and Pietenpol, J. A. (2003). The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell. Biol. 23, 2264-2276.
47. Wong, P. P., Pickard, A. and McCance, D. J. (2010). p300 alters keratinocyte cell growth and differentiation through regulation of p21(Waf1/CIP1). PLoS ONE 5, e8369.
48. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dotsch, V., Andrews, N. C., Caput, D. and McKeon, F. (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2, 305-316.
49. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C. et al. (1999). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398, 714-718.
50. Yang, A., Zhu, Z., Kapranov, P., McKeon, F., Church, G. M., Gingeras, T. R. and Struhl, K. (2006). Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol. Cell 24, 593-602.
51. Yi, R., Poy, M. N., Stoffel, M. and Fuchs, E. (2008). A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452, 225-229.
52. Yu, Z. K., Gervais, J. L. and Zhang, H. (1998). Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc. Natl. Acad. Sci. USA 95, 11324-11329.
53. Zhu, L. (2010). Skp2 knockout reduces cell proliferation and mouse body size: and prevents cancer? Cell Res. 20, 605-607.